Kanaph Therapeutics Inc. Stock: price and insider trades · South Korea
카나프테라퓨틱스
1 insider bought shares over the last 90 days, the latest by 박창원, filed 02 Nov 2026.
Who traded when
BuySale+6 other insiders
Since the insiders bought
- -75.2%Entry ₩36,700 · Close 30 Oct 2026 ₩9,100
- -75.2%Entry ₩36,700 · Close 30 Oct 2026 ₩9,100
- -75.2%Entry ₩36,700 · Close 30 Oct 2026 ₩9,100
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 3,000 sharesShareKRXDART:20261102000023Canonical exit: 31 Jan 2027 (T+90)
- Other0DART
- 35,000 sharesShareKRXDART:20260720000187Canonical exit: 18 Oct 2026 (T+90)
- 8,250 sharesShareKRXDART:20260522000434Canonical exit: 20 Aug 2026 (T+90)
- 25,000 sharesShareKRXDART:20260522000428Canonical exit: 20 Aug 2026 (T+90)
- 4,500 sharesShareKRXDART:20260522000442Canonical exit: 20 Aug 2026 (T+90)
- 261,844 sharesKRXDART:20260423000440
- 10,000 shares@ ₩11,777.80100.0% of flowShareKRXDART:20260422000503Canonical exit: 16 Jul 2026 (T+90)
- 60,000 shares@ ₩7,300.00100.0% of flowShareKRXDART:20260422000468Canonical exit: 16 Jul 2026 (T+90)
- 4,000 shares@ ₩1,500.00100.0% of flowShareKRXDART:20260422000507Canonical exit: 16 Jul 2026 (T+90)
- 3,500 shares@ ₩6,160.00100.0% of flowShareKRXDART:20260422000476Canonical exit: 16 Jul 2026 (T+90)
- 2,000 shares@ ₩6,160.00100.0% of flowShareKRXDART:20260323000837Canonical exit: 18 Jun 2026 (T+90)
- 10,000 shares@ ₩1,500.00100.0% of flowShareKRXDART:20260323000807Canonical exit: 18 Jun 2026 (T+90)
- 11,000 shares@ ₩3,194.5455100.0% of flowShareKRXDART:20260323000890Canonical exit: 18 Jun 2026 (T+90)
- 752,163 sharesKRXDART:20260323000331Canonical exit: 14 Jun 2026 (T+90)
- 374,644 sharesKRXDART:20260319000519Canonical exit: 14 Jun 2026 (T+90)
- 900,892 sharesKRXDART:20260319000491Canonical exit: 14 Jun 2026 (T+90)
- 1,424,333 sharesShareKRXDART:20260317000685Canonical exit: 14 Jun 2026 (T+90)
- 1,570,482 sharesShareKRXDART:20260317000615Canonical exit: 14 Jun 2026 (T+90)
- 5,013,135 sharesKRXDART:20260317000652Canonical exit: 14 Jun 2026 (T+90)
- 150,000 sharesShareKRXDART:20260317000587Canonical exit: 14 Jun 2026 (T+90)
- 207,000 sharesShareKRXDART:20260317000574Canonical exit: 14 Jun 2026 (T+90)
- 285,000 sharesShareKRXDART:20260317000598Canonical exit: 14 Jun 2026 (T+90)
- ●Executives0DART
24 of 24 declarations
About Kanaph Therapeutics Inc.
Ten filers bought shares of 카나프테라퓨틱스 (Kanaph Therapeutics Inc.) from March 16 to March 20, 2026. Across the full history, 7 purchase filings are classed as clustered. The whole record of this South Korean health care company, valued at KRW 138.0 billion, fits in 22 filings, published from March 16 to July 20, 2026, for trades dated March 16 to April 17, 2026.
The tally: 20 purchases, 1 sale and 1 filing of another kind, or 95% purchases among open-market trades. Seven purchases carry an amount, EUR 370,417 in all with a median of EUR 12,354. The largest, EUR 250,974, is by 박창원 (부사장) on April 17; next come EUR 67,487 for 정하연 (상무) the same day, then EUR 20,346 for 김동건 (이사) on March 20. 장지훈 (부사장) filed 4 purchases, 김동건 and 김남주 (상무) 3 each, and Lee Byoung Chul (대표이사) 2.
Read moreShow less
Insiders hold 35.7% of the capital. Filings are published a median of 3 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
